Medical and economic burden of influenza in the elderly population in central and eastern European countries

Gábor Kovács, Z. Kaló, Karina Jahnz-Rozyk, Jan Kyncl, Agnes Csohan, Adriana Pistol, Mariya Leleka, Rafail Kipshakbaev, Laure Durand, Bérengère Macabeo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Influenza affects 5-15% of the population during an epidemic. In Western Europe, vaccination of at-risk groups forms the cornerstone of influenza prevention. However, vaccination coverage of the elderly (

Original languageEnglish
Pages (from-to)428-440
Number of pages13
JournalHuman Vaccines and Immunotherapeutics
Volume10
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Medical Economics
Human Influenza
Vaccination
Population

Keywords

  • Cost of illness
  • Elderly
  • Health care system
  • Influenza
  • Public health
  • Vaccination

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology
  • Medicine(all)

Cite this

Medical and economic burden of influenza in the elderly population in central and eastern European countries. / Kovács, Gábor; Kaló, Z.; Jahnz-Rozyk, Karina; Kyncl, Jan; Csohan, Agnes; Pistol, Adriana; Leleka, Mariya; Kipshakbaev, Rafail; Durand, Laure; Macabeo, Bérengère.

In: Human Vaccines and Immunotherapeutics, Vol. 10, No. 2, 2014, p. 428-440.

Research output: Contribution to journalArticle

Kovács, G, Kaló, Z, Jahnz-Rozyk, K, Kyncl, J, Csohan, A, Pistol, A, Leleka, M, Kipshakbaev, R, Durand, L & Macabeo, B 2014, 'Medical and economic burden of influenza in the elderly population in central and eastern European countries', Human Vaccines and Immunotherapeutics, vol. 10, no. 2, pp. 428-440. https://doi.org/10.4161/hv.26886
Kovács, Gábor ; Kaló, Z. ; Jahnz-Rozyk, Karina ; Kyncl, Jan ; Csohan, Agnes ; Pistol, Adriana ; Leleka, Mariya ; Kipshakbaev, Rafail ; Durand, Laure ; Macabeo, Bérengère. / Medical and economic burden of influenza in the elderly population in central and eastern European countries. In: Human Vaccines and Immunotherapeutics. 2014 ; Vol. 10, No. 2. pp. 428-440.
@article{7b61d907bf594ddc9b744cf26d9f44c4,
title = "Medical and economic burden of influenza in the elderly population in central and eastern European countries",
abstract = "Influenza affects 5-15{\%} of the population during an epidemic. In Western Europe, vaccination of at-risk groups forms the cornerstone of influenza prevention. However, vaccination coverage of the elderly (",
keywords = "Cost of illness, Elderly, Health care system, Influenza, Public health, Vaccination",
author = "G{\'a}bor Kov{\'a}cs and Z. Kal{\'o} and Karina Jahnz-Rozyk and Jan Kyncl and Agnes Csohan and Adriana Pistol and Mariya Leleka and Rafail Kipshakbaev and Laure Durand and B{\'e}reng{\`e}re Macabeo",
year = "2014",
doi = "10.4161/hv.26886",
language = "English",
volume = "10",
pages = "428--440",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",
number = "2",

}

TY - JOUR

T1 - Medical and economic burden of influenza in the elderly population in central and eastern European countries

AU - Kovács, Gábor

AU - Kaló, Z.

AU - Jahnz-Rozyk, Karina

AU - Kyncl, Jan

AU - Csohan, Agnes

AU - Pistol, Adriana

AU - Leleka, Mariya

AU - Kipshakbaev, Rafail

AU - Durand, Laure

AU - Macabeo, Bérengère

PY - 2014

Y1 - 2014

N2 - Influenza affects 5-15% of the population during an epidemic. In Western Europe, vaccination of at-risk groups forms the cornerstone of influenza prevention. However, vaccination coverage of the elderly (

AB - Influenza affects 5-15% of the population during an epidemic. In Western Europe, vaccination of at-risk groups forms the cornerstone of influenza prevention. However, vaccination coverage of the elderly (

KW - Cost of illness

KW - Elderly

KW - Health care system

KW - Influenza

KW - Public health

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=84896958145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896958145&partnerID=8YFLogxK

U2 - 10.4161/hv.26886

DO - 10.4161/hv.26886

M3 - Article

VL - 10

SP - 428

EP - 440

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 2

ER -